03 June 2022 - Events
Performed a landscape analysis for a Fortune 500 company in the vaccine/LNP space.
Performed an IP diligence for a gene therapy company that helped the client obtain ~$75 million in early series financing.
Actively counsels clients on strategic management of complex patent portfolios related to medical device instruments.
Completed an IP due diligence for a major acquisition by a Fortune 500 client in the immunotherapeutic space.
State of Massachusetts
US Patent and Trademark Office
‘Patent Cases To Watch In 2022,’ Law360, January 3, 2022, quoted
‘Withers Launches Venture Capital and Life Sciences Team in Boston,’ Intellectual Property Magazine, April 20, 2021, featured
‘News Digest: On the Move,’ World Trademark Review, April 20, 2021, featured
‘Joys and Challenges of IP Practice at the Intersection of Science and Business,’ Corporate Counsel Business Journal, July 2018
‘To Seek Design Protection or Not, That is the Question!,’ co-author, April 2017
Little Cumberland Island Wildlife Refuge, Board Member (2013-present)
Long Range Planning Committee, Member (1996-2006)
‘Life Sciences CEO Forum,’ December 2020, Boston, MA (presenter)
‘Patents 101: Protecting Innovations,’ December 2019, New Orleans, LA (presenter)
‘The World of Gene Therapy Intellectual Property,’ April 2018, Boston, MA (presenter)
‘Obviousness-type Double Patenting Rejections,’ November 2017, Boston, MA (presenter)
‘The World of Bispecific Antibody Intellectual Property,’ September 2017, Boston, MA (presenter)
‘IP Issues When Exporting to the U.S. & Strategies for U.S. Patent Disputes,’ August 2017, Qingdao, China (presenter)
‘Securing Intellectual Property Patent Rights in the United States,’ August 2017, Beijing, China (presenter)
‘Patent Transparency & Improvement Act: Come Take a Troll with Me,’ March 2014, Boston, MA (presenter)
‘Considerations for Universities Claiming Micro-entity Status,’ August 2013, Boston, MA (presenter)
InsightView all Firm insight
25 May 2022 - Events
In-person seminar | Relocating into or out of the US – US Tax and Succession Planning Considerations
18 May 2022 - Article